Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ST8SIA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
XRN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KYNU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PELI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ICAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANGEL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MT1F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
REL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FILIP1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFE2L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM171 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPAG9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on